Stroke and Vascular Neurology

Papers
(The TQCC of Stroke and Vascular Neurology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
MetS in the prediction of asymptomatic intracranial arterial stenosis: the potential mediating role of hsCRP245
Photochemically induced thalamus infarction impairs cognition in a mouse model82
Oxidised low-density lipoprotein and adverse outcome in patients with acute mild ischaemic stroke or high-risk TIA: a secondary analysis of the INSPIRES randomised clinical trial60
Efficacy and safety of Y-3 intracalvariosseous injection versus intravenous injection in the treatment of acute large hemispheric infarction (SOLUTION-2): rationale and design of a multicentre, prospe51
Prediction of futile recanalisation after endovascular treatment in acute ischaemic stroke: development and validation of a hybrid machine learning model48
Efficacy of immediate anti-hypertensive treatment in patients with acute ischaemic stroke stratified by mean arterial pressure and pulse pressure: a secondary analysis of the China Antihypertensive Tr40
Multiomics genetic insights into potential molecular targets for intracranial aneurysm36
Dural sinus septum: an underlying cause of cerebral venous sinus stenting failure and complications34
Carotid artery endarterectomy in patients with symptomatic non-stenotic carotid artery disease31
Mechanical thrombectomy with combined stent retriever and contact aspiration versus stent retriever alone for acute large vessel occlusion: data from ANGEL-ACT registry31
Intravenous tenecteplase compared with alteplase for minor ischaemic stroke: a secondary analysis of the AcT randomised clinical trial29
Stepwise improvement in intracerebral haematoma expansion prediction with advanced imaging: a comprehensive comparison of existing scores29
Acute right insular ischaemic lesions and poststroke left ventricular dysfunction29
KRAS mutation-induced EndMT of brain arteriovenous malformation is mediated through the TGF-β/BMP-SMAD4 pathway27
Characteristics, temporal trends and outcomes of intravenous thrombolysis in Chinese patients aged>80 years who had a stroke26
Would integrated Western and traditional Chinese medicine have more benefits for stroke rehabilitation? A systematic review and meta-analysis23
Detailed phenotype ofRNF213p.R4810K variant identified by the Chinese patients with acute ischaemic stroke or transient ischaemic attack22
Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial21
Frequency, predictors and cardiovascular outcomes associated with transthoracic echocardiographic findings during acute ischaemic stroke hospitalisation21
Development of machine learning-based models to predict 10-year risk of cardiovascular disease: a prospective cohort study21
LRRC8A in endothelial cells contributes to the aberrant blood-brain barrier integrity in ischaemic stroke20
Pipeline Embolization Device for intracranial aneurysms presenting with mass effect: a large Chinese cohort20
Thrombus migration in patients with acute ischaemic stroke undergoing endovascular thrombectomy19
Angioarchitecture and prognosis of pediatric intracranial pial arteriovenous fistula18
Endovascular treatment for basilar artery occlusion: a meta-analysis18
Linking the Paul Coverdell National Acute Stroke Program to commercial claims to establish a framework for real-world longitudinal stroke research18
Poststroke motor, cognitive and speech rehabilitation with brain–computer interface: a perspective review18
Arteriolosclerosis differs from venular collagenosis in relation to cerebrovascular parenchymal damages: an autopsy-based study17
Effect of haemodynamics on the risk of ischaemic stroke in patients with severe vertebral artery stenosis17
Call for emergency action to limit global temperature increases, restore biodiversity and protect health17
Discontinuation of antiplatelet therapy after stent-assisted coil embolisation of cerebral aneurysm: a nationwide cohort study17
Ten-year follow-up investigation of stroke risk in systemic lupus erythematosus16
CCL17 exerts neuroprotection through activation of CCR4/mTORC2 axis in microglia after subarachnoid haemorrhage in rats16
Treatment with intravenous alteplase in ischaemic stroke patients with onset time between 4.5 and 24 hours (HOPE): protocol for a randomised, controlled, multicentre study16
Low LDL-C level and intracranial haemorrhage risk after ischaemic stroke: a prospective cohort study15
STING mediates microglial pyroptosis via interaction with NLRP3 in cerebral ischaemic stroke15
Enhanced diagnostic workup increases pathological findings in patients with acute ischaemic stroke: results of the prospective HEBRAS study15
Cerebrovascular cinematic rendering of multisystemic smooth muscle dysfunction syndrome14
Endovascular therapy in acute anterior circulation large vessel occlusive patients with a large infarct core (ANGEL-ASPECT): protocol of a multicentre randomised trial13
Childhood strokes in China describing clinical characteristics, risk factors and performance indicators: a case-series study13
Extracellular vesicles bearing serum amyloid A1 exacerbate neuroinflammation after intracerebral haemorrhage13
Racial disparities in access to, and outcomes of, acute ischaemic stroke treatments in the USA13
Quantitative histopathological analysis of thrombi retrieved by mechanical thrombectomy and their association with stroke aetiology13
Src inhibition rescues FUNDC1-mediated neuronal mitophagy in ischaemic stroke13
Incidence and predictors of futile recanalisation after endovascular therapy in acute vertebrobasilar artery occlusion patients: insight from the ANGEL-ACT registry12
Thrombolytic agents, more options, more challenges12
Baseline systolic blood pressure and efficacy of dual antiplatelet in acute ischaemic stroke12
Central post-stroke pain: advances in clinical and preclinical research11
Dual regulation of Atf3 and Lonp1 as therapeutic targets in cerebral ischaemia-reperfusion injury11
Mobile stroke care expedites intravenous thrombolysis and endovascular thrombectomy11
Retrograde recanalisation for vertebral artery stump syndrome: a case report11
Development, validation and comparison of multivariable risk scores for prediction of total stroke and stroke types in Chinese adults: a prospective study of 0.5 million adults11
Rationale and design of the GOLDEN BRIDGE II: a cluster-randomised multifaceted intervention trial of an artificial intelligence-based cerebrovascular disease clinical decision support system to impro11
Sex differences in the epidemiology of spontaneous and traumatic cervical artery dissections11
Inflammatory biomarkers and cerebral small vessel disease: a community-based cohort study10
Advance Consent for participation in Acute Stroke Trials (ACTION): protocol for a feasibility study10
Prediction of large vessel occlusion for ischaemic stroke by using the machine learning model random forests10
Endovascular treatment with or without intravenous alteplase for acute ischaemic stroke due to basilar artery occlusion10
DRug-coated Balloon for Endovascular treatment of sYmptOmatic intracraNial stenotic Disease (DR. BEYOND): the protocol of a multicentre randomised trial10
Cerebral haemodynamics in symptomatic intracranial atherosclerotic disease: a narrative review of the assessment methods and clinical implications10
Definitions of white matter hyperintensity change: impact on estimates of progression and regression10
Rationale and design of Low-Frequency REpetitive TRanscranial Magnetic Stimulation Combined with Endovascular Treatment in ACute Ischaemic StrokE (RETRACE II): a randomised double-blind controlled mul10
Association between statin therapy and the risk of stroke in patients with moyamoya disease: a nationwide cohort study10
Surgical timing and long-term outcomes in patients with severe haemorrhagic spinal cord cavernous malformations9
Oestrogen ameliorates blood-brain barrier damage after experimental subarachnoid haemorrhage via the SHH pathway in male rats9
Comparison of the Pipeline embolisation device alone or combined with coiling for treatment of different sizes of intracranial aneurysms9
Loss of life expectancy due to stroke and its subtypes in urban and rural areas in China, 2005–20209
Efficacy of butylphthalide in preventing cognitive decline in ischaemic stroke survivors: a 12-month prospective following-up study9
Exploring the relationship between embolic acute stroke distribution and supra-aortic vessel patency: key findings from an in vitro model study9
Cisternostomy for malignant middle cerebral artery infarction: proposed pathophysiological mechanisms and preliminary results9
Exosomes-mediated delivery of miR-486-3p alleviates neuroinflammation via SIRT2-mediated inhibition of mitophagy after subarachnoid hemorrhage9
CSA declaration of next-generation reperfusion therapy for ischaemic stroke9
Safety and efficacy of glibenclamide on cerebral oedema following aneurysmal subarachnoid haemorrhage: a randomised, double-blind, placebo-controlled clinical trial9
Antithrombotic therapy in patients with COVID-19: indications, pharmacotherapy and controversy8
COP27 climate change conference: urgent action needed for Africa and the world8
Somatic mutation contributing to clonal haematopoiesis is a risk factor of recurrent stroke in first-ever acute ischaemic stroke: a prospective cohort study8
Preclinical evaluation of ZL006-05, a new antistroke drug with fast-onset antidepressant and anxiolytic effects8
Correction:Cilostazol and isosorbide mononitrate for the prevention of progression of : baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850)8
Young stroke in Bangladesh: addressing rare cases with diagnostic challenges and much-needed solutions8
Dl-3-n-butylphthalide attenuates brain injury caused by cortical infarction accompanied by cranial venous drainage disturbance8
Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study8
Real-world analysis of two ischaemic stroke and TIA systolic blood pressure goals on 12-month mortality and recurrent vascular events8
Differential associations of lipoprotein(a) level with cerebral large artery and small vessel diseases8
Effect of intravenous alteplase before endovascular therapy for atherothrombotic stroke-related large vessel occlusion: subanalysis of the RESCUE AT-LVO registry8
Rationale and design of a randomised double-blind 2×2 factorial trial comparing the effect of a 3-month intensive statin and antiplatelet therapy for patients with acute mild ischaemic stroke or high-8
Improving detection of cerebral small vessel disease aetiology in patients with isolated lobar intracerebral haemorrhage8
Why non-human primates are needed in stroke preclinical research8
Tenecteplase Reperfusion therapy in Acute ischaemic Cerebrovascular Events-II (TRACE II): rationale and design8
Intra-arterial thrombolytics during endovascular thrombectomy for acute ischaemic stroke in the MR CLEAN Registry8
0.048232078552246